Mass General Brigham
Boston, Massachusetts, 02114, United States
NCT Number: NCT06625983
The research question we pose is, Does a colorectal cancer (CRC) screening decision support tool offered in advance of primary care visits increase CRC screening completion rates? Our work aims to answer this question by evaluating the effectiveness of an MGB decision support tool to 1) promote informed decisions about CRC screening for average risk patients ages 45-75, 2) deploy a decision support tool as part of a primary care bundle questionnaire, and 3) support patients in completing their preferred method of CRC screening.
Looking for future studies?
Notify Me45 year–75 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
As part of usual care, a CRC screening electronic decision support tool developed by Mass General Brigham has been integrated into Epic. This decision support tool is part of routine clinical care and is sent electronically to patients aged 45-75 who receive the Annual Visit Primary Care Screening Bundled Questionnaire in advance of their annual visit. Patients complete the tool on Patient Gateway prior to the visit or via an iPad at the visit. The decision support tool guides patients through the CRC screening options (e.g., FIT, colonoscopy, Cologuard) to help them select their preferred screening method. As part of routine care, the patient will be prompted to complete the tool as part of the bundled questionnaire, and the results will be available in the Epic encounter in the Screenings tab with the other screening bundle responses. The primary care clinician can then discuss the options and/or screening preference with the patient. Depending on what the patient and clinician decide, a CRC screening test may be ordered for the patient. As a secondary outcome, a random sample of 1000 patients will be surveyed to understand their involvement in the decision making process and 300 providers will be surveyed to understand how the decision tool impacted the conversation with the patient. The IRB to conduct surveys of patients and providers was approved by the Mass General Brigham IRB (Protocol # 2024P002568).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adults aged 45-75 overdue for CRC screening at average risk of CRC have an annual visit scheduled with participating practices
Exclusion criteria
CRC decision tool included in the primary care bundle questionnaire
Other names: intervention
Time frame: 12 months
Assessment of electronic health record data to determine completion of CRC screening by any modality
Time frame: During the 6 month intervention phase
Provider-reported question: Did you feel the CRC screening tool informed or affected your conversations in any way?
Time frame: During the 6 month intervention phase
Patient-reported survey question about involvement in the decision making process.
Massachusetts General Hospital
Other
Colorectal Cancer Screening Decision Support Tool in the Primary Care Bundle Questionnaire
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06982053
Colonic Diseases, Colorectal Cancer Control and Prevention
Wuhan, China
View Trial DetailsNCT07158203
Behavior, Behavior Change
Oslo, Norway
View Trial DetailsNCT07107152
Colorectal Cancer Control and Prevention
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01929122
Colorectal Cancer Control and Prevention
Fort Collins, Colorado, United States
View Trial Details